Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty

Croatian Medical Journal

Volumn 54, Issue 4, 2013, Pages 355-361

  Mraovic, Boris ^a   Hipszer, Brian R ^a   Epstein, Richard H ^a   Parvizi, Javad ^a   Pequignot, Edward C ^b   Chervoneva, Inna ^b   Joseph, Jeffery I ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; SURGICAL RISK; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ADULT; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HIP JOINT; HUMANS; INCIDENCE; KNEE JOINT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884945323     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2013.54.355     Document Type: Article

References (19)

1. Cheung BM, Ong KL, Man YB, Wong LY, Lau CP, Lam KS. Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999- 2002 according to different defining criteria. J Clin Hypertens (Greenwich). 2006;8:562-70. Medline:16896272 doi:10.1111/j.15246175.2006.05414.x
2. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEPDefined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older. Diabetes. 2003;52:1210-4. Medline:12716754 doi:10.2337/diabetes.52.5.1210
3. Ford ES. Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S. Diabetes Care. 2005;28:2745-9. Medline:16249550 doi:10.2337/ diacare.28.11.2745
4. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158:1525-31. Medline:9679793 doi:10.1001/archinte.158.14.1525
5. Bjornara BT, Gudmundsen TE, Dahl OE. Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br. 2006;88:386-91. Medline:16498018
6. Zhan C, Kaczmarek R, Loyo-Berrios N, Sangl J, Bright RA. Incidence and short-term outcomes of primary and revision hip replacement in the United States. J Bone Joint Surg Am. 2007;89:526-33. Medline:17332101 doi:10.2106/JBJS.F.00952
7. Lie SA, Engesaeter LB, Havelin LI, Furnes O, Vollset SE. Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999. Acta Orthop Scand. 2002;73:392-9. Medline:12358110 doi:10.1080/00016470216312
8. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52. Medline:16157765 doi:10.1161/ CIRCULAT IONAHA.105.169404
9. Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R, et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost. 2006;4:1914-8. Medline:16848878 doi:10.1111/j.1538- 7836.2006.02132.x
10. A mbrosetti M, Ageno W, Salerno M, Pedretti RF, Salerno-Uriarte JA. Metabolic syndrome as a risk factor for deep vein thrombosis after acute cardiac conditions. Thromb Res. 2007;120:815-8. Medline:17509670 doi:10.1016/j.thromres.2007.02.005
11. Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty. 2010;25:64-70. Medline:19056217 doi:10.1016/j.arth.2008.10.002
12. Huo MH, Salvati EA, Sharrock NE, Brien WW, Sculco TP, Pellicci PM, et al. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial. Clin Orthop Relat Res. 1992;274:35-46. Medline:1729021
13. Parvizi J, Smith EB, Pulido L, Mamelak J, Morrison WB, Purtill JJ, et al. The rise in the incidence of pulmonary embolus after joint arthroplasty: is modern imaging to blame? Clin Orthop Relat Res. 2007;463:107-13. Medline:17621232
14. Ay C, Tengler T, Vormittag R, Simanek R, Dorda W, Vukovich T, et al. Venous thromboembolism-a manifestation of the metabolic syndrome. Haematologica. 2007;92:374-80. Medline:17339187 doi:10.3324/haematol.10828
15. Ray JG. Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment. Curr Opin Pulm Med. 2003;9:378-84. Medline:12904707 doi:10.1097/00063198- 200309000-00007
16. Mantilla CB, Horlocker TT , Schroeder DR, Berry DJ, Brown DL. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology. 2003;99:552-60. Medline:12960538 doi:10.1097/00000542-200309000-00009
17. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, Fitzgerald G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br. 2007;89:799-807. Medline:17613508
18. Dentali F, Romualdi E, Ageno W. The metabolic syndrome and the risk of thrombosis. Haematologica. 2007;92:297-9. Medline:17339177 doi:10.3324/haematol.11243
19. Brietzke SA. Controversy in diagnosis and management of the metabolic syndrome. Med Clin North Am. 2007;91:1041-61. Medline:17964908 doi:10.1016/j.mcna.2007.06.005